|
|
|
School
|
Status
|
Round
|
Year
|
GMAT
GRE
|
GPA
|
YOE
Years of Experiance
|
Post-MBA industry
|
Location
|
Date
|
|---|---|---|---|---|---|---|---|---|---|
|
Kellogg
Full Time MBA |
Admitted, ($$$)
|
Round 1 | 2025 | 685 GMAT Focus | 3.8 | 7 | Finance: Venture Capital | United States |
15 Dec 2024 09:08 PM
|
|
Booth
Full Time MBA |
Admitted, ($$$)
|
Round 1 | 2025 | 685 GMAT Focus | 3.8 | 7 | Finance: Venture Capital | United States |
15 Dec 2024 09:08 PM
|
|
Yale
Full Time MBA |
Denied without Interview
|
Round 1 | 2025 | 685 GMAT Focus | 5 | Finance | China |
15 Dec 2024 07:35 PM
|
|
|
Booth
Full Time MBA |
Denied with Interview
|
Round 1 | 2025 | 685 GMAT Focus | 5 | Finance | China |
15 Dec 2024 07:34 PM
|
|
|
Tuck
Full Time MBA |
Waitlisted with Interview
|
Round 1 | 2025 | 685 GMAT Focus | 5 | Finance | China |
15 Dec 2024 07:33 PM
|
|
|
LBS
Full Time MBA |
Admitted, ($)
|
Round 1 | 2025 | 3.4 | 7 | Consulting | India |
15 Dec 2024 10:42 AM
|
|
|
Olin St. Louis
Full Time MBA |
Admitted
|
Round 1 | 2025 |
15 Dec 2024 04:10 AM
|
|||||
|
LBS
Masters in Management |
Admitted
|
R1 | 2025 | 710 GMAT Classic | 25 | 1 | Finance: Investment Banking | Morocco |
14 Dec 2024 06:19 PM
|
|
IIM Ahmedabad
PGPX |
Admitted
|
Round 2 | 2025 | 645 GMAT Focus | 3.6 | 5 | Consulting | India |
14 Dec 2024 07:49 AM
|
|
Foster
Full Time MBA |
Admitted, ($$)
|
Round 1 | 2025 | 655 GMAT Focus | 8.5 | 6 | Consulting | India |
14 Dec 2024 07:37 AM
|
|
Marshall (USC)
Marshall (USC) Exective MBA |
Waitlisted with Interview
|
Round 1 | 2025 | Waiver | 3.8 | 5 | Consulting | United States |
14 Dec 2024 07:12 AM
|
|
Darden
Full Time MBA |
Denied without Interview
|
Round 1 | 2025 | 740 GMAT Classic | 8.7 | 4 | Healthcare/Pharmaceuticals | India |
14 Dec 2024 06:46 AM
|
|
Columbia
Full Time MBA |
Denied without Interview
|
Round 1 | 2025 | 740 GMAT Classic | 8.7 | 4 | Healthcare/Pharmaceuticals | India |
14 Dec 2024 06:46 AM
|
|
Fuqua
Full Time MBA |
Waitlisted with Interview
|
Round 1 | 2025 | 740 GMAT Classic | 8.7 | 4 | Healthcare/Pharmaceuticals | India |
14 Dec 2024 06:46 AM
|
|
Kellogg
Full Time MBA |
Denied with Interview
|
Round 1 | 2025 | 740 GMAT Classic | 8.7 | 4 | Healthcare/Pharmaceuticals | India |
14 Dec 2024 06:46 AM
|
|
Marshall (USC)
Full Time MBA |
Waitlisted with Interview
|
Round 1 | 2025 | Waiver | 3.7 | 2 | Consulting | India |
14 Dec 2024 04:54 AM
|
|
Owen Vanderbilt
Full Time MBA |
Admitted, ($$$)
|
Round 1 | 2025 | 330 GRE | 3.7 | 0 | Consulting | India |
14 Dec 2024 04:02 AM
|
|
Owen Vanderbilt
Full Time MBA |
Admitted, ($$$)
|
Round 1 | 2025 | 330 GRE | 3.7 | 0 | Consulting | India |
14 Dec 2024 04:02 AM
|
|
Judge Cambridge
Full Time MBA |
Admitted, ($)
|
Round 2 | 2025 | 680 GMAT Classic | 3.6 | 4 | Consulting | Thailand |
14 Dec 2024 03:43 AM
|
|
Marshall (USC)
Full Time MBA |
Denied with Interview
|
Round 1 | 2025 | 760 GMAT Classic | 6.4 | 5 | Technology | India |
14 Dec 2024 02:03 AM
|